Aristides Capital LLC Takes $230,000 Position in Addus HomeCare Co. (NASDAQ:ADUS)

Aristides Capital LLC purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 1,984 shares of the company’s stock, valued at approximately $230,000.

Other institutional investors and hedge funds have also modified their holdings of the company. UMB Bank n.a. grew its holdings in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the period. Quest Partners LLC bought a new stake in Addus HomeCare in the second quarter valued at about $31,000. EntryPoint Capital LLC acquired a new position in Addus HomeCare in the first quarter valued at about $44,000. Innealta Capital LLC acquired a new position in Addus HomeCare in the second quarter valued at about $44,000. Finally, GAMMA Investing LLC boosted its holdings in Addus HomeCare by 40.8% during the first quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after buying an additional 161 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on ADUS shares. TD Cowen upped their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 target price for the company. Finally, Stephens restated an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a report on Tuesday, August 6th. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $128.29.

Insider Activity at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,917 shares of company stock valued at $3,050,082. Insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Up 1.6 %

Shares of ADUS opened at $133.03 on Tuesday. The company has a 50 day moving average of $128.48 and a 200-day moving average of $115.67. The stock has a market capitalization of $2.41 billion, a P/E ratio of 33.01, a P/E/G ratio of 2.40 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $78.35 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.94 EPS. On average, sell-side analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.